New methods for evaluation of impact of FDA drug safety communications

Ended Awarded Last action

Contract number
HHSF22301001T
Awardee
Awarding agency
Obligated
$1,276,295

Award facts

Contract value 100% obligated
$1,276,295.08 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC
B537 Special Studies/Analysis- Medical/Health
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Mission Hill, MA 02120, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 4 $0
Change Order 3 $0
Other Administrative Action 2 $0
Change Order 1 $0
Original award $1,276,295

Quick answers

Who was awarded contract HHSF22301001T?

HHSF22301001T was awarded to Brigham & Womens Hospital Inc. by Food and Drug Administration (Department of Health and Human Services) on September 13, 2013.

How much is contract HHSF22301001T worth?

The government has obligated $1,276,295 on HHSF22301001T.

Is contract HHSF22301001T an order under another contract?

Yes. HHSF22301001T is a delivery order under HHSF223201000008I, an indefinite delivery contract.

Was contract HHSF22301001T competed?

The extent of competition for HHSF22301001T was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award